Quick answers
- What is Erythromycin lactobionate used for?
- The FDA-approved label (Erythrocin Lactobionate, Hospira, Inc., October 30, 2025) says: “Erythrocin Lactobionate-IV (erythromycin lactobionate for injection, USP) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Erythromycin lactobionate have a boxed warning?
- No. None of the 4 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Erythromycin lactobionate?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Erythromycin lactobionate been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Erythromycin lactobionate?
- 4 companies list prescription products of Erythromycin lactobionate in the FDA NDC Directory, including Armas Pharmaceuticals Inc., Hospira, Inc. and Gland Pharma Limited.
What Erythromycin lactobionate is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Erythrocin Lactobionate-IV (erythromycin lactobionate for injection, USP) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin. …
— FDA label: Erythrocin Lactobionate, Hospira, Inc., effective October 30, 2025. Read the full label on DailyMed →
The FDA has 4 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 4 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, powder, lyophilized, for solution · Injection, powder, for solution |
|---|---|
| Route | Intravenous |
| Prescription products | 4 in the FDA NDC Directory |
| Brand names | Erythrocin Lactobionate |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Armas Pharmaceuticals Inc.1 product
- Hospira, Inc.1 product
- Gland Pharma Limited1 product
- Piramal Critical Care Inc1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA050609 ERYTHROCIN | Hospira | September 24, 1986 | 22, latest November 18, 2022 2022: Labeling · 2019: Labeling · 2018: Labeling |
Generic approvals (1)
- ANDA216761Gland · November 19, 2024
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 1668264, 1668267 |
|---|---|
| SPL set ID of the quoted label | a96c405f-bd70-4bb4-719e-ac6a79dcc213 |
| FDA labels (SPL) | 4 |
| FDA applications | NDA050609, 1 ANDA |
| Active ingredients (FDA) | ERYTHROMYCIN LACTOBIONATE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Erythrocin Lactobionate, Hospira, Inc., effective October 30, 2025; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →